A Delaware court has dismissed a derivative lawsuit against Axsome Therapeutics, Inc., a biopharmaceutical company, ruling that the claims were time-barred. The decision affects stockholders of Axsome and highlights the importance of timely legal action in corporate governance disputes.
The case, titled In Re Axsome Therapeutics, Inc. Stockholder Derivative Litigation (C.A. No. 2025-1076-LWW), was decided on July 9, 2026, by Vice Chancellor Will. The court found that the plaintiffs, John A. Wickstrom and John Gildea, failed to act on their claims within the three-year statute of limitations period, which began when they were on inquiry notice of the alleged wrongdoing.
Background
Axsome Therapeutics, Inc. is focused on developing therapies for central nervous system disorders. One of its key products, AXS-07, faced regulatory setbacks that led to a significant drop in the company’s stock price in April 2022. Following this drop, stockholders filed a class action in federal court, alleging that Axsome and its officers made false statements about the drug's prospects.
In response to the regulatory issues, Wickstrom and Gildea sought to file a derivative lawsuit. They claimed that Axsome's management breached their fiduciary duties by misleading investors about the company's drug development process. However, they did not file their derivative complaint until September 2025, despite being aware of the issues as early as April 2022.
The Ruling
The court ruled that the plaintiffs' claims were barred by the doctrine of laches, which applies when a party delays in bringing a lawsuit and that delay prejudices the other party. Vice Chancellor Will stated, "The plaintiffs in this derivative action slept on their rights. They acknowledge that they were on inquiry notice of their claims by April 2022... Only as the end of the three-year limitations period loomed did the plaintiffs send demands to inspect the company’s records."
The court emphasized that the plaintiffs failed to timely assert their claims, and the defendants were entitled to a presumption of prejudice due to the delay. The ruling concluded that the plaintiffs did not present extraordinary circumstances to rebut this presumption, leading to the dismissal of the case.
Impact
This ruling serves as a reminder for stockholders and corporate governance advocates about the importance of acting promptly when they suspect wrongdoing by company management. The court's decision reinforces the principle that delays in asserting claims can result in the loss of legal rights, particularly in derivative actions where the statute of limitations is strictly enforced.
Moreover, the ruling may deter other stockholders from pursuing similar claims if they do not act swiftly. It highlights the necessity for stockholders to remain vigilant and proactive in monitoring the actions of corporate management to protect their interests.
What's Next
The plaintiffs may have the option to appeal the decision, but further details on whether they plan to do so were not available in the court filing. Additionally, related cases may still be pending in federal court, but the outcome of those cases will not impact the dismissal of this derivative action.